CTNNB1 and liver cancer: Thus, our findings strongly suggest the existence of a SL interaction between HGS and oncogenic CTNNB1 in HuH6 and HCT116 cells; nonetheless, further investigation is required to validate HGS as a new therapeutic target for liver cancers with CTNNB1 mutations.